Mirae Asset Launches Global X China MedTech ETF

Share post:

Mirae Asset Global Investments (Hong Kong) Limited has introduced a new ETF called the Global X China MedTech ETF (2841), which has been listed on the Hong Kong Stock Exchange. This ETF provides investors with access to Chinese companies operating in the medical technology sector, specializing in medical equipment, devices, and consumables.

The launch of this thematic ETF expands Mirae Asset’s range of investment products that focus on long-term disruptive trends. Given China’s rapidly growing medical device market, driven by an aging population, there are expected growth opportunities in the MedTech sector. It is projected to expand from RMB 1.2 trillion in 2022 to RMB 3.5 trillion by 2030, reflecting a compound annual growth rate (CAGR) of 14%.

Investors in the Global X China MedTech ETF can gain diversified exposure to various subsectors within the industry, including medical equipment, consumables, in-vitro diagnostics, and consumer medtech.

Mr. Wanyoun CHO, Chief Executive Officer of Mirae Asset Global Investments (Hong Kong) Limited, expressed enthusiasm about expanding their thematic ETF suite to target growth opportunities in the Chinese market. As Chinese innovators redefine the domestic, regional, and global economy, this ETF offers a unique opportunity for investors to participate in this dynamic market.

ETF Newz Says:

The Global X China MedTech ETF (2841) tracks the Solactive China MedTech Index. Mirae Asset now offers a total of 27 ETFs listed in Hong Kong, including 18 thematic ETFs, providing a diverse range of investment capabilities from thematic growth and income to core and commodities.

Related

Maintain Your Horses! A Space Bitcoin ETF May perhaps well also Already Be Priced into Crypto.

There is a growing belief that the recent price surge in bitcoin could already factor in the potential approval of a spot Bitcoin ETF- a pivotal strategic investment move that holds significant influence in the crypto market. Investors and financial enthusiasts alike are keenly awaiting regulatory approval, a decision that could potentially catalyze the future growth trajectory of bitcoin prices. This speculation underscores not only the potential value that bitcoin holds as a digital asset but also the evolving role of institutional reactiveness in the cryptocurrency landscape.

Tim Draper’s Bold Prediction: Bitcoin (BTC) Price Set to Skyrocket to $250K!

In the world of finance, Bitcoin is increasingly recognized as a transformative force. With the potential to challenge...

Bitcoin ETF: Navigating the Perils of SEC Rejection and Fierce Opposition from Funds

A recent court order has directed the Securities and Exchange Commission (SEC) to reconsider its denial of Grayscale's...

Nike’s Shocking 10% Plunge: Sales Outlook Slashed

Nike, a leading athletic apparel⁢ company, ⁣recently announced plans to reduce costs by $2 ‍billion over the next...